Skip to content

Clinical trials

Terminated Phase 2 Primary Myelofibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 2 Status: Terminated Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20065
20071
20083
20091
20102
20132
20142
20153
20161
20174
20181
20192
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lee Moffitt Cancer Center and Research Institute3
M.D. Anderson Cancer Center3
Mayo Clinic3
Fred Hutchinson Cancer Center2
Incyte Corporation2
Novartis Pharmaceuticals2
OHSU Knight Cancer Institute2
University of Utah2
Barbara Ann Karmanos Cancer Institute1
Baylor College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis37
Myeloproliferative Disorders16
Leukemia, Lymphocytic, Chronic, B-Cell13
Leukemia, Myeloid, Acute13
Myelodysplastic Syndromes13
Multiple Myeloma11
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Leukemia10
Polycythemia Vera10
Leukemia, Myelomonocytic, Chronic9

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.